AMWL

American Well Corp

7 filings tracked

healthcarecloud computingSMALL ($300M-2B)

Signal Magnitude Chart

bullish

bearish

neutral

Signal Timeline

bearishMay 5

Revenue declined 18% year-over-year to $54.9 million.

earnings miss

70%

bullishMay 5

Operating expenses reduced by 26% through aggressive headcount and asset cuts.

margin expansion

60%

neutralMay 5

Company maintains a high cash balance but continues to operate at a net loss.

dilution risk

30%

bearishMay 5

Revenue declined 18% year-over-year to $54.9 million.

earnings miss

70%

bullishMay 5

Operating expenses reduced by 26% through aggressive headcount and asset cuts.

margin expansion

60%

neutralMay 5

Company maintains a high cash balance but continues to operate at a net loss.

dilution risk

30%

bearishMay 5

Revenue declined 18% year-over-year to $54.9 million.

earnings miss

70%

bullishMay 5

Operating expenses reduced by 26% through aggressive headcount and asset cuts.

margin expansion

60%

neutralMay 5

Company maintains a high cash balance but continues to operate at a net loss.

dilution risk

30%

bearishMay 5

Revenue declined 18% year-over-year to $54.9 million.

earnings miss

70%

bullishMay 5

Operating expenses reduced by 26% through aggressive headcount and asset cuts.

margin expansion

60%

neutralMay 5

Company maintains a high cash balance but continues to operate at a net loss.

dilution risk

30%

bearishMay 5

Revenue declined 18% year-over-year to $54.9 million.

earnings miss

70%

bullishMay 5

Operating expenses reduced by 26% through aggressive headcount and asset cuts.

margin expansion

60%

neutralMay 5

Company maintains a high cash balance but continues to operate at a net loss.

dilution risk

30%

bearishMay 5

Revenue declined 18% year-over-year to $54.9 million.

earnings miss

70%

bullishMay 5

Operating expenses reduced by 26% through aggressive headcount and asset cuts.

margin expansion

60%

neutralMay 5

Company maintains a high cash balance but continues to operate at a net loss.

dilution risk

30%

bearishMay 5

Revenue declined 18% year-over-year to $54.9 million.

earnings miss

70%

bullishMay 5

Operating expenses reduced by 26% through aggressive headcount and asset cuts.

margin expansion

60%

neutralMay 5

Company maintains a high cash balance but continues to operate at a net loss.

dilution risk

30%

Filing History

10-QMay 5, 2026

The Q1 2026 filing presents a company in a race against time to align its cost structure with a shrinking revenue profile. Amwell has successfully reduced its cash burn and operating losses through aggressive austerity, but the top-line contraction and deteriorating cash conversion rates remain significant headwinds. The shift toward a 'hybrid care' platform is a strategic necessity, but the immediate financial impact is a mix of leaner operations and declining sales. Investors are left weighing a debt-free balance sheet and a reduced loss profile against the risks of extreme customer concentration and a struggling subscription model. The next twelve months will be critical, as the company must prove it can stabilize its revenue and convert its remaining performance obligations into cash without further eroding its market position or requiring additional equity financing.